- Latest Headlines
- Gates Vascular Institute Performs First Cardiac Cryoablations
- Daughter of WCHOB Doctor to Appear on "Jeopardy!"
- Luminosa Winterguard Give Away Teddy Bears at Women & Children’s Hospital
- Kaleida Health Announces Chief Medical Officer Appointments
- Karola Long, RN Named 2014 Perinatal Nurse of the Year by the Buffalo Prenatal-Perinatal Network
- View All Headlines
- Kaleida in the News
- Media Advisories
- Press Releases
- Facts at a Glance
- KYI Newsletter
726 Exchange Street
Buffalo, NY 14210
Dr. Quattrin is a Leading Researcher for Major Grant to Study Potential Treatment for Type 1 Diabetes
Teresa Quattrin, M.D., Pediatrician-in-Chief, Women & Children's Hospital of Buffalo, and Professor of Pediatrics, Chair, Department of Pediatrics, University of New York at Buffalo, is a leading researcher for a $600,000 grant awarded by the American Diabetes Association to further a pilot study conducted that found that a drug used to treat Type 2 diabetes could also help Type 1 diabetics.
If the initial findings on liraglutide are confirmed in the larger study, it could mean the first significant new treatment for Type 1 diabetes since insulin’s discovery in the 1920s.
|Related Kaleida Service: Endocrinology/Diabetes|